PunjiPUNJI
Live AI ↗
Sectoral/ ThematicITI Asset Management Limited

ITI Pharma and Healthcare Fund - Direct Plan - Growth Option

Benchmark: Nifty Healthcare Index TRI · Riskometer: Very High

₹20.2852

NAV (2026-08-31)

₹276.23 Cr

AUM (2026-08-31)

0.92%

EXPENSE RATIO (DIRECT)

2021-10-18

INCEPTION

BQuality · 68.2/100
CSafety · 58.1/100
BCompound · 78.3/100

Punji Fund Health Score - percentile-within-category. See methodology.

CHART

Rolling CAGR by holding period - min, median, max

Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.

-18%4.2%26%48%70%1Y3Y
Min rolling CAGRMedian rolling CAGRMax rolling CAGR
MetricValuePercentileCategory median
3Y Rolling CAGR21.6%81.55th 17.5%
3Y Sharpe Ratio0.9783.78th 0.63
3Y Alpha0.6%30.91th 2.7%
3Y Std Deviation15.2%46.85th (lower is better)15.0%

0.9662

Sharpe Ratio

1.4513

Sortino Ratio

0.6491

Alpha (%)

0.9427

Beta

15.1511

Std Deviation (%)

-17.0738

Max Drawdown (%)

93.5943

Up Capture

90.1052

Down Capture

5.4658

Tracking Error (%)

1.2609

Calmar Ratio

3-year window vs. Nifty Healthcare Index TRI.

CHART

Top sector holdings

Share of portfolio (% to NAV) in each of the top sectors.

70.45%21.09%TOP 10100%
Pharmaceuticals & Biotechnology 70.45%Healthcare Services 21.09%Other 2.11%Healthcare Equipment & Supplies 1.52%Consumer Durables 1.23%Chemicals & Petrochemicals 1.1%Retailing 0.88%Industrial Products 0.69%Aerospace & Defense 0.47%Banks 0.46%

TOP HOLDINGS

Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)13.26%
Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)7.97%
Apollo Hospitals Enterprise Limited (Healthcare Services)6.05%
Max Healthcare Institute Limited (Healthcare Services)5.05%
Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)4.84%
Cipla Limited (Pharmaceuticals & Biotechnology)4.43%
Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)4.41%
Laurus Labs Limited (Pharmaceuticals & Biotechnology)4.21%
Aurobindo Pharma Limited (Pharmaceuticals & Biotechnology)3.84%
Mankind Pharma Limited (Pharmaceuticals & Biotechnology)3.39%

Funds that behave most similarly (beta, capture ratios, volatility - not holdings overlap). Pick up to 2 to compare alongside this fund:

47.0538

P/E Ratio

10.04

P/B Ratio

0.4254

Dividend Yield (%)

27.83

Active Share (%)

0.53

Portfolio Turnover - Total (%)

CHART

Asset Allocation

As of Jul-2026

97.89%TOP 3100%
Equity 97.89%Debt 0%Cash 2.11%

CHART

Market Cap Split

As of Jul-2026

36.55%39.9%21.44%TOP 398%
Large 36.55%Mid 39.9%Small 21.44%

Portfolio analytics as of Jul-2026.

Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.